The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine

NCT00724815 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

530

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine Disorders

Interventions

DRUG: NP101 - Sumatriptan iontophoretic transdermal patch
DRUG: Placebo

Sponsor

NuPathe Inc.